Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Aldeyra Therapeutics, Inc. (ALDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/29/2022 8-K Investor presentation
Docs: "Slide Presentation of Aldeyra Therapeutics, Inc.",
"Aldeyra Therapeutics to Announce Top-Line Data for Systemic RASP Modulator ADX-629 at 2022 Research & Development Day"
02/28/2019 8-K Quarterly results
06/26/2018 8-K Investor presentation
Docs: "Slide presentation of Aldeyra Therapeutics, Inc.",
"Aldeyra Therapeutics Announces Development Programs at 2018 Research Day Expanded Pipeline Features Distinct Mechanisms of Action Across Five Product Candidates Three Additional Clinical Programs Planned for 2019 LEXINGTON, Mass., June 26, 2018 / — Aldeyra Therapeutics, Inc. , a biotechnology company devoted to the development of next-generation medicines to improve the lives of patients with immune-mediated diseases, announced product development programs in systemic inflammatory disease, retinal disease, and cancer at the company's 2018 Research Day. “Complementing our late-stage product candidate reproxalap, we have continued to execute on our mission of expanding our pipeline across multiple mechanisms of action and multiple molecular compositions,” commented Todd C. Brady, M.D., Ph.D...."
09/26/2016 8-K Investor presentation
Docs: "Slide presentation of Aldeyra Therapeutics, Inc.",
"Aldeyra Therapeutics Provides Update on Late-Stage Clinical Trials at 2016 Research and Development Day"
03/31/2016 8-K Investor presentation
Docs: "Presentation Slides"
03/09/2016 8-K Investor presentation
Docs: "Presentation Slides"
03/02/2015 8-K Investor presentation
Docs: "Presentation slides",
"Investor Contact:"
09/05/2014 8-K Investor presentation
Docs: "Presentation slides",
"Aldeyra Therapeutics to Present at Upcoming Investor Conferences Burlington, MA, September 5, 2014 Aldeyra Therapeutics, Inc. , a biotechnology company focused on the development of products to treat diseases related to free aldehydes, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present corporate overviews at the 16th Annual Rodman & Renshaw Global Investment Conference, taking place September 8, 2014 through September 10, 2014 in New York, New York, and the Aegis Capital Corporation 2014 Healthcare and Technology Conference, taking place on September 10, 2014 through September 13, 2014 in Las Vegas, Nevada. Details of the presentations are as follows: 16th Annual Rodman & Renshaw Global Investment Conference Date: Wednesday, September 10, 2014 Time:..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy